Skip to content

Effect of Ocular Exercise and Drakshadi Ghrita (Tarpana) with Shatavaryadi Churna in Timira (Simple Hypermetropia)

Evaluation of Ocular Exercise and Drakshadi Ghrita (Tarpana) with Shatavaryadi Churna in Timira (Simple Hypermetropia) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055375
Enrollment
30
Registered
2023-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H520- Hypermetropia

Interventions

None listed

Sponsors

Uttarakhand Ayurved University Dehradun
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients presenting with classical features of Prathama patalgata Timira after proper screening with the help of Snellenâ??s chart, retinoscopy and computerized auto refractometry will be selected irrespective of sex, occupation, religion etc. 1 Patient having symptoms of Prathama patalgata Timira 2 Patient aged between 12 to 35 years. 3 Patients having simple hypermetropia (+0.5DS to +6.0DS of vision)

Exclusion criteria

Exclusion criteria: 1 Dwitiya, Tritiya and Chaturtha Patalgata Timira 2 Astigmatism 3 Congenital hypermetropia 4 Anomalies like accommodation insufficiency, Presbyopia. 5 Patient with any other anterior & posterior segment ocular pathology like amblyopia, strabismus , cataract, glaucoma, uveitis, retinal pathology.. 6 Patient with any systemic disease like Hypertension, Diabetes Mellitus, Tuberculosis. 7 Non vaccinated (covid-19) patients.

Design outcomes

Primary

MeasureTime frame
a. Blurred vision b. Eye strain c. Watering of eyes d. Headache e. Snellenâ??s Chart for vision f. Ocular examination-a.Retinoscopy (Wet & Dry), b.Auto Refractometry, c. Refraction (Wet & Dry ) d. External examination of head ,forehead , Eyebrows, Eyelids, Lid margins, Conjuctiva , Cornea , & Eye movements will be done to rule out any abnormalities. Timepoint: 35 days

Secondary

MeasureTime frame
a. Blurred vision b. Eye strain c. Watering of eyes d. Headache e. Snellenâ??s Chart for vision and Follow Up study will be conducted for 1 month (15 days interval) after completion of treatment.Timepoint: 1 month.

Countries

India

Contacts

Public ContactJyoti Panwar

Rishikul Campus, Haridwar, Uttarakhand Ayurved University (Dehradun)

gunjan06sharma@gmail.com9258030654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026